MY100938A
(en)
*
|
1986-06-06 |
1991-05-31 |
Ciba Geigy Ag |
Arylkylimidazole derivatives.
|
US5138069A
(en)
*
|
1986-07-11 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
US4851423A
(en)
*
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
IL86134A
(en)
*
|
1987-05-02 |
1993-06-10 |
Basf Ag |
N-substituted azoles, their manufacture and their use as pesticides and compositions containing them
|
US4820843A
(en)
*
|
1987-05-22 |
1989-04-11 |
E. I. Du Pont De Nemours And Company |
Tetrazole intermediates to antihypertensive compounds
|
US5081127A
(en)
*
|
1988-01-07 |
1992-01-14 |
E. I. Du Pont De Nemours And Company |
Substituted 1,2,3-triazole angiotensin II antagonists
|
US5189048A
(en)
*
|
1988-01-07 |
1993-02-23 |
E. I. Du Pont De Nemours And Company |
Substituted 1,2,3 triazole angiotensin II antagonists
|
US5315013A
(en)
*
|
1988-01-07 |
1994-05-24 |
E. I. Du Pont De Nemours And Company |
Substituted pyrazole angiotensin II antagonists
|
CA1338238C
(fr)
*
|
1988-01-07 |
1996-04-09 |
David John Carini |
Imidazoles bloquant les recepteurs de l'angiotensine ii et combinaisons de ces imidazoles avec des diuretiques et des anti-inflammatoires non steroidiens
|
US5210079A
(en)
*
|
1988-01-07 |
1993-05-11 |
E. I. Du Pont De Nemours And Company |
Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
|
US5015651A
(en)
*
|
1988-01-07 |
1991-05-14 |
E. I. Du Pont De Nemours And Company |
Treatment of hypertension with 1,2,4-angiotensin II antagonists
|
US5354867A
(en)
*
|
1988-12-06 |
1994-10-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
US4916129A
(en)
*
|
1989-01-19 |
1990-04-10 |
E. I. Du Pont De Nemours And Company |
Combination β-blocking/angiotensin II blocking antihypertensives
|
DE3928177A1
(de)
*
|
1989-04-08 |
1991-02-28 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
CA2016710A1
(fr)
*
|
1989-05-15 |
1990-11-15 |
Prasun K. Chakravarty |
Benzimidazoles substitues comme antagonistes de l'antiotensine ii
|
GB8911854D0
(en)
*
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
US5157026A
(en)
*
|
1989-05-30 |
1992-10-20 |
Merck & Co., Inc. |
Oxo-purines as angiotensin II antagonists
|
US5332744A
(en)
*
|
1989-05-30 |
1994-07-26 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
IL94390A
(en)
*
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
US5064825A
(en)
*
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
DE69034103T2
(de)
*
|
1989-06-14 |
2004-07-15 |
Smithkline Beecham Corp. |
Imidazoalkensäure
|
US5312828A
(en)
*
|
1989-06-14 |
1994-05-17 |
Finkelstein Joseph A |
Substituted imidazoles having angiotensin II receptor blocking activity
|
US5418250A
(en)
*
|
1989-06-14 |
1995-05-23 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
EP0403158A3
(fr)
*
|
1989-06-14 |
1991-12-18 |
Smithkline Beecham Corporation |
Acides imidazolyl-alcénoiques
|
US5185351A
(en)
*
|
1989-06-14 |
1993-02-09 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
WO1991000277A1
(fr)
*
|
1989-06-30 |
1991-01-10 |
E.I. Du Pont De Nemours And Company |
Imidazoles substitues
|
EP0479892A1
(fr)
*
|
1989-06-30 |
1992-04-15 |
E.I. Du Pont De Nemours And Company |
Imidazoles a substitution aryle a anneau fusionne
|
US5240928A
(en)
*
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
CA2020073A1
(fr)
*
|
1989-07-03 |
1991-01-04 |
Eric E. Allen |
Quinazolinones substitues comme antagonistes de l'angiotensine ii
|
EP0407342A3
(en)
*
|
1989-07-06 |
1991-07-10 |
Ciba-Geigy Ag |
Pyrimidine derivatives
|
EP0409332A3
(en)
*
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
ATE113281T1
(de)
*
|
1989-08-02 |
1994-11-15 |
Takeda Chemical Industries Ltd |
Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
|
EP0412848B1
(fr)
*
|
1989-08-11 |
1995-01-18 |
Zeneca Limited |
Dérivés de quinoléine, procédés pour leur préparation et leur utilisation comme médicaments
|
US5100897A
(en)
*
|
1989-08-28 |
1992-03-31 |
Merck & Co., Inc. |
Substituted pyrimidinones as angiotensin ii antagonists
|
IE70593B1
(en)
*
|
1989-09-29 |
1996-12-11 |
Eisai Co Ltd |
Biphenylmethane derivative the use of it and pharmacological compositions containing same
|
US5298518A
(en)
*
|
1989-09-29 |
1994-03-29 |
Eisai Co., Ltd. |
Biphenylmethane derivative and pharmacological use
|
EP0424317A3
(en)
*
|
1989-10-19 |
1991-09-25 |
Ciba-Geigy Ag |
Pyrimidines
|
IL95975A
(en)
*
|
1989-10-24 |
1997-06-10 |
Takeda Chemical Industries Ltd |
N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
|
US5250554A
(en)
*
|
1989-10-24 |
1993-10-05 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives useful as angiotensin II inhibitors
|
CA2027937A1
(fr)
*
|
1989-10-25 |
1991-04-26 |
Richard M. Keenan |
5-¬(tetrazolyle)alcenyle|imidazoles substitues
|
US5177096A
(en)
*
|
1989-10-25 |
1993-01-05 |
Smithkline Beecham Corporation |
Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical methods of use thereof
|
IL96019A0
(en)
*
|
1989-10-31 |
1991-07-18 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
|
US5248689A
(en)
*
|
1989-11-06 |
1993-09-28 |
Smithkline Beecham Corporation |
Substituted N-(imidazolyl)alkyl alanine derivatives
|
CA2028925A1
(fr)
*
|
1989-11-06 |
1991-05-07 |
Gerald R. Girard |
Derives substitues de la n-(imidazolyl)alkylalanine
|
PT95899A
(pt)
*
|
1989-11-17 |
1991-09-13 |
Glaxo Group Ltd |
Processo para a preparacao de derivados indole
|
IE903911A1
(en)
*
|
1989-11-20 |
1991-05-22 |
Ici Plc |
Diazine derivatives
|
US5073566A
(en)
*
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
US5104891A
(en)
*
|
1989-12-11 |
1992-04-14 |
G. D. Searle & Co. |
Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
|
EP0434038A1
(fr)
*
|
1989-12-22 |
1991-06-26 |
Takeda Chemical Industries, Ltd. |
Dérivés condensés d'imidazole, leur préparation et leur utilisation
|
US5234917A
(en)
*
|
1989-12-29 |
1993-08-10 |
Finkelstein Joseph A |
Substituted 5-(alkyl)carboxamide imidazoles
|
ZA9010460B
(en)
*
|
1989-12-29 |
1992-11-25 |
Univ Technologies Int |
Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
|
US5449682A
(en)
*
|
1990-02-13 |
1995-09-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted benzyl element
|
CA2036304C
(fr)
*
|
1990-02-15 |
2001-04-17 |
Takehiko Naka |
Derives de la pyrimidinedione; preparation et utilisation
|
DE59107440D1
(de)
*
|
1990-02-19 |
1996-04-04 |
Ciba Geigy Ag |
Acylverbindungen
|
MY106533A
(en)
*
|
1990-02-20 |
1995-06-30 |
Sumitomo Chemical Co |
A 4-tert.-butyl imidazole derivative and its production and use.
|
US5284661A
(en)
*
|
1990-02-22 |
1994-02-08 |
Takeda Chemical Industries, Ltd. |
Fused thiophene derivatives, their production and use
|
CA2037630C
(fr)
*
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Composes heterocycliques renfermant de l'azote, methode de production et applications correspondantes
|
NZ237476A
(en)
*
|
1990-03-20 |
1994-01-26 |
Sanofi Sa |
N-substituted heterocyclic compounds and pharmaceutical compositions.
|
US5270317A
(en)
*
|
1990-03-20 |
1993-12-14 |
Elf Sanofi |
N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
|
FR2665702B1
(fr)
*
|
1990-08-08 |
1994-02-25 |
Sanofi |
Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
FR2659967B1
(fr)
*
|
1990-03-20 |
1992-07-24 |
Sanofi Sa |
Derives d'imidazolinone n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5166206A
(en)
*
|
1990-03-30 |
1992-11-24 |
Merck & Co., Inc. |
Substituted pyrimidines, pyrimidinones and pyridopyrimidines
|
DE4010797A1
(de)
*
|
1990-04-04 |
1991-10-10 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
|
US5196444A
(en)
*
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
GB2244054B
(en)
*
|
1990-04-19 |
1994-04-06 |
Ici Plc |
Pyridine derivatives
|
US5198439A
(en)
*
|
1990-04-19 |
1993-03-30 |
Imperial Chemical Industries Plc |
Angiotension II antagonizing pyridine derivatives
|
ZA912983B
(en)
|
1990-04-27 |
1992-01-29 |
Takeda Chemical Industries Ltd |
Benzimidazole derivatives,their production and use
|
US6004989A
(en)
*
|
1990-04-27 |
1999-12-21 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
US5703110A
(en)
*
|
1990-04-27 |
1997-12-30 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
US5098920A
(en)
*
|
1990-05-04 |
1992-03-24 |
G. D. Searle & Co. |
1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
|
RU2147875C1
(ru)
|
1990-05-11 |
2000-04-27 |
Пфайзер Инк. |
Способ и композиция для снижения кровяного давления и лечения застойной сердечной недостаточности у млекопитающего
|
US5821232A
(en)
*
|
1990-05-11 |
1998-10-13 |
Pfizer Inc. |
Synergistic therapeutic compositions and methods
|
US5045540A
(en)
*
|
1990-05-25 |
1991-09-03 |
Warner-Lambert Co. |
Amino acid derivatives with angiotensin II antagonist properties
|
FR2663028B1
(fr)
*
|
1990-06-08 |
1994-10-14 |
Roussel Uclaf |
Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
FR2674523A1
(fr)
*
|
1991-03-28 |
1992-10-02 |
Roussel Uclaf |
Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
FR2670489B1
(fr)
*
|
1990-12-18 |
1994-10-14 |
Roussel Uclaf |
Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
EP0461039B1
(fr)
*
|
1990-06-08 |
1998-09-16 |
Hoechst Marion Roussel |
Dérivés du benzimidazole, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
|
AU653524B2
(en)
|
1990-06-08 |
1994-10-06 |
Roussel-Uclaf |
New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
|
AU7983691A
(en)
*
|
1990-06-15 |
1992-01-07 |
G.D. Searle & Co. |
1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders
|
NZ238688A
(en)
*
|
1990-06-28 |
1992-05-26 |
Smithkline Beecham Corp |
Substituted histidines: pharmaceutical compositions, preparation and uses thereof
|
CA2036147A1
(fr)
*
|
1990-06-29 |
1991-12-30 |
Hiroki Tomioka |
Derive de 1-pyridylimidazole ainsi que sa production et son utilisation
|
FR2664271B1
(fr)
*
|
1990-07-05 |
1994-02-18 |
Roussel Uclaf |
Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
IL98319A
(en)
*
|
1990-07-05 |
1997-04-15 |
Roussel Uclaf |
Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
|
FR2675503B1
(fr)
*
|
1991-04-19 |
1994-02-18 |
Roussel Uclaf |
Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
CA2044806A1
(fr)
*
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Derives de purine
|
DE4023215A1
(de)
*
|
1990-07-21 |
1992-01-23 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
|
NZ239161A
(en)
*
|
1990-07-31 |
1994-01-26 |
Smithkline Beecham Corp |
Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
|
GB9017482D0
(en)
*
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Manufacturing process
|
GB9017480D0
(en)
*
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Chemical process
|
AU8534291A
(en)
*
|
1990-08-10 |
1992-03-02 |
G.D. Searle & Co. |
Renal-selective angiotensin ii antagonists for treatment of hypertension
|
US5089626A
(en)
*
|
1990-08-23 |
1992-02-18 |
Merck & Co., Inc. |
Process for preparing an angiotensin II antagonist
|
US5217985A
(en)
*
|
1990-08-28 |
1993-06-08 |
G. D. Searle & Co. |
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
|
US5229406A
(en)
*
|
1990-09-19 |
1993-07-20 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5140036A
(en)
*
|
1990-09-19 |
1992-08-18 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5091390A
(en)
*
|
1990-09-20 |
1992-02-25 |
E. I. Du Pont De Nemours And Company |
Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs
|
EP0481614A1
(fr)
*
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Pyridopyrimidinones substituées et hétérocyles apparantés comme antagonistes de la angiotensine II
|
US5126342A
(en)
*
|
1990-10-01 |
1992-06-30 |
Merck & Co., Inc. |
Imidazole angiotensin ii antagonists incorporating acidic functional groups
|
WO1992007852A1
(fr)
*
|
1990-10-25 |
1992-05-14 |
G.D. Searle & Co. |
Composes de xanthine de biphenylalkyle pour le traitement de troubles cardiovasculaires
|
AU636066B2
(en)
*
|
1990-10-30 |
1993-04-08 |
Takeda Chemical Industries Ltd. |
Thienoimidazole derivatives, their production and use
|
US5238952A
(en)
*
|
1990-10-31 |
1993-08-24 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
US5087634A
(en)
*
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
GB9025123D0
(en)
*
|
1990-11-19 |
1991-01-02 |
Ici Plc |
Nitrogen compounds
|
EP0563238B1
(fr)
*
|
1990-12-14 |
2002-05-22 |
Smithkline Beecham Corporation |
Acides imidazolyl-alcenoiques
|
US5175180A
(en)
*
|
1990-12-20 |
1992-12-29 |
G. D. Searle & Co. |
N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds and use for treatment of circulatory disorders
|
CA2058198A1
(fr)
*
|
1991-01-04 |
1992-07-05 |
Adalbert Wagner |
Procede de preparation et utilisation de derives d'azole
|
IE914572A1
(en)
*
|
1991-01-17 |
1992-07-29 |
Zeneca Ltd |
Chemical process
|
IE914573A1
(en)
*
|
1991-01-17 |
1992-07-29 |
Ici Plc |
Boron compounds
|
AT395853B
(de)
*
|
1991-01-31 |
1993-03-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
IE920175A1
(en)
*
|
1991-02-11 |
1992-08-12 |
Zeneca Ltd |
Nitrogen heterocycles
|
GB9102803D0
(en)
*
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Pyridine compounds
|
US5472967A
(en)
*
|
1991-02-20 |
1995-12-05 |
Synthelabo |
4-pyrimidinone derivatives their preparation and their application in therapy
|
FR2672892B1
(fr)
*
|
1991-02-20 |
1994-01-14 |
Synthelabo |
Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.
|
US5616599A
(en)
*
|
1991-02-21 |
1997-04-01 |
Sankyo Company, Limited |
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
|
CA2061607C
(fr)
*
|
1991-02-21 |
1999-01-19 |
Hiroaki Yanagisawa |
Derives 1-biphenylimidazole, leur preparation et leur utilisation therapeutique
|
US5187271A
(en)
*
|
1991-02-28 |
1993-02-16 |
G. D. Searle & Co. |
N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
|
US6008368A
(en)
*
|
1993-04-28 |
1999-12-28 |
G. D. Searle & Co. |
Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists
|
EP0502575A1
(fr)
*
|
1991-03-06 |
1992-09-09 |
Merck & Co. Inc. |
1-(2H)-Isoquinoleinones substituées
|
US5385894A
(en)
*
|
1991-03-06 |
1995-01-31 |
Merck & Co., Inc. |
Disubstituted 6-aminoquinazolinones
|
US5202328A
(en)
*
|
1991-03-06 |
1993-04-13 |
Merck & Co., Inc. |
Substituted fused pyrimidinones
|
US5191086A
(en)
*
|
1991-03-19 |
1993-03-02 |
E.R. Squibb & Sons, Inc. |
Imidazole and benzimidazole derivatives
|
US5236928A
(en)
*
|
1991-03-19 |
1993-08-17 |
Merck & Co., Inc. |
Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
|
EP0505098A1
(fr)
*
|
1991-03-19 |
1992-09-23 |
Merck & Co. Inc. |
Dérivés d'imidazole ayant des groupes fonctionnels acides comme angiotensin II antagonistes
|
US5206235A
(en)
*
|
1991-03-20 |
1993-04-27 |
Merck & Co., Inc. |
Benzo-fused lactams that promote the release of growth hormone
|
US5196537A
(en)
*
|
1991-03-21 |
1993-03-23 |
G. D. Searle & Co. |
5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5187179A
(en)
*
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
US5128327A
(en)
*
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
US5177074A
(en)
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5164403A
(en)
*
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
US5155117A
(en)
*
|
1991-04-12 |
1992-10-13 |
G. D. Searle & Co. |
1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
|
TW274551B
(fr)
*
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
US5190942A
(en)
*
|
1991-04-22 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
|
CZ227093A3
(en)
*
|
1991-04-29 |
1994-03-16 |
Merck & Co Inc |
Mixture suitable for the preparation of tablets by direct moulding
|
US5198438A
(en)
*
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5506361A
(en)
*
|
1991-05-08 |
1996-04-09 |
Theupjohn Company |
Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
|
US5223501A
(en)
*
|
1991-05-10 |
1993-06-29 |
Merck & Co., Inc. |
Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
|
GB9110625D0
(en)
*
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
GB9110636D0
(en)
*
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
US5332820A
(en)
*
|
1991-05-20 |
1994-07-26 |
E. I. Du Pont De Nemours And Company |
Dibenzobicyclo(2.2.2) octane angiotensin II antagonists
|
US5175164A
(en)
*
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
FR2677984B1
(fr)
*
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5210211A
(en)
*
|
1991-06-21 |
1993-05-11 |
Warner-Lambert Company |
4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
|
IL102183A
(en)
*
|
1991-06-27 |
1999-11-30 |
Takeda Chemical Industries Ltd |
The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
|
US5177097A
(en)
*
|
1991-07-24 |
1993-01-05 |
E. R. Squibb & Sons, Inc. |
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
|
DE69216013T2
(de)
*
|
1991-09-10 |
1997-05-07 |
Tanabe Seiyaku Co |
Imidazoindolizinderivate mit Angiotensin-II Hemmwirkung
|
CA2077419C
(fr)
*
|
1991-09-10 |
1998-08-25 |
Yasushi Honma |
Derives imidazopyridine et procede pour leur preparation
|
DE69232003T2
(de)
*
|
1991-09-18 |
2002-04-25 |
Glaxo Group Ltd |
Benzanilidderivate als 5-HT1D-Antagonisten
|
PT100905A
(pt)
*
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
AT398202B
(de)
*
|
1991-10-04 |
1994-10-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
US5187159A
(en)
*
|
1991-10-07 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
|
US5149699A
(en)
*
|
1991-10-24 |
1992-09-22 |
American Home Products Corporation |
Substituted pyridopyrimidines useful as antgiotensin II antagonists
|
US5256654A
(en)
*
|
1991-10-24 |
1993-10-26 |
American Home Products Corporation |
Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
|
US5484937A
(en)
*
|
1992-08-04 |
1996-01-16 |
G.D. Searle & Co. |
N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders
|
US5252753A
(en)
*
|
1991-11-01 |
1993-10-12 |
Ortho Pharmaceutical Corporation |
Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
|
US5389661A
(en)
*
|
1991-12-05 |
1995-02-14 |
Warner-Lambert Company |
Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
|
US5322950A
(en)
*
|
1991-12-05 |
1994-06-21 |
Warner-Lambert Company |
Imidazole with angiotensin II antagonist properties
|
US5350752A
(en)
*
|
1991-12-16 |
1994-09-27 |
E. R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5234923A
(en)
*
|
1991-12-16 |
1993-08-10 |
E. R. Squibb & Sons, Inc. |
Substitute indole and benzimidazole derivatives
|
US5212177A
(en)
*
|
1991-12-16 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Indole and benzimidazole-substituted dihydropyrimidine derivatives
|
US5308853A
(en)
*
|
1991-12-20 |
1994-05-03 |
Warner-Lambert Company |
Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
|
EP0550313A1
(fr)
*
|
1991-12-30 |
1993-07-07 |
Synthelabo |
Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
|
FR2685697B1
(fr)
*
|
1991-12-30 |
1994-02-04 |
Synthelabo |
Nouveaux derives de 2-(tetrazol-5-yl)-(1,1'-biphenyle), leur preparation et leur utilisation comme intermediaires de synthese.
|
US5240953A
(en)
*
|
1992-01-30 |
1993-08-31 |
Ortho Pharmaceutical Corporation |
Substituted triazoles as angiotensin ii inhibitors
|
US5312958A
(en)
*
|
1992-01-31 |
1994-05-17 |
Takeda Chemical Industries, Ltd. |
Process for producing 4-bromomethylbiphenyl compounds
|
DE4206043A1
(de)
*
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl-substituierte imidazole
|
TW215434B
(fr)
*
|
1992-03-07 |
1993-11-01 |
Hoechst Ag |
|
US5208234A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
US5208235A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole derivatives
|
FR2689508B1
(fr)
*
|
1992-04-01 |
1994-06-17 |
Fournier Ind & Sante |
Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
|
US5972990A
(en)
*
|
1992-04-10 |
1999-10-26 |
Brigham And Women's Hospital, Inc. |
Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
|
US5378704A
(en)
*
|
1992-04-15 |
1995-01-03 |
E. R. Squibb & Sons, Inc. |
Non-peptidic angiotensin-II-receptor-antagonists
|
US5294722A
(en)
*
|
1992-04-16 |
1994-03-15 |
E. R. Squibb & Sons, Inc. |
Process for the preparation of imidazoles useful in angiotensin II antagonism
|
US5214153A
(en)
*
|
1992-04-23 |
1993-05-25 |
Merck & Co., Inc. |
Actinoplanes transformation process anti-hypertensive compound and method of use thereas
|
US5218125A
(en)
*
|
1992-04-23 |
1993-06-08 |
Merck & Co., Inc. |
Antihypertensive compound and method of use thereas
|
US5217882A
(en)
*
|
1992-05-18 |
1993-06-08 |
Merck & Co., Inc. |
Microbial transformation process for producing antihypertensive N2 -glucuronide products
|
DK0573218T3
(da)
*
|
1992-06-02 |
2001-06-18 |
Sankyo Co |
4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse
|
US5401851A
(en)
*
|
1992-06-03 |
1995-03-28 |
Eli Lilly And Company |
Angiotensin II antagonists
|
US5583229A
(en)
*
|
1992-12-07 |
1996-12-10 |
Eisai Co., Ltd. |
Process for the preparation of imidazopyridine derivatives
|
DE4221009A1
(de)
*
|
1992-06-26 |
1994-01-05 |
Bayer Ag |
Imidazolyl-substituierte Cyclohexanderivate
|
EP0577023A3
(en)
*
|
1992-07-01 |
1996-12-18 |
Hoechst Ag |
Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
|
US5484955A
(en)
*
|
1992-07-06 |
1996-01-16 |
Takeda Chemical Industries, Ltd. |
Tri-higher alkyl tin azide and its use
|
GB9218449D0
(en)
|
1992-08-29 |
1992-10-14 |
Boots Co Plc |
Therapeutic agents
|
IT1255461B
(it)
*
|
1992-07-28 |
1995-11-02 |
Luso Farmaco Inst |
Eteri di imidazoli ad attivita' a ii antagonista
|
US5283241A
(en)
*
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5583130A
(en)
*
|
1992-09-25 |
1996-12-10 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5317017A
(en)
*
|
1992-09-30 |
1994-05-31 |
Merck & Co., Inc. |
N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
|
DE4242459A1
(de)
*
|
1992-12-16 |
1994-06-23 |
Merck Patent Gmbh |
Imidazopyridine
|
CA2111662C
(fr)
*
|
1992-12-17 |
2004-11-23 |
Hiroaki Yanagisawa |
Derives de biphenyles, leur preparation et leur utilisation pour le traitement de l'hypertension et des maladies cardiaques
|
DE4302956A1
(de)
*
|
1993-02-03 |
1994-08-04 |
Bayer Ag |
Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
|
US5284841A
(en)
*
|
1993-02-04 |
1994-02-08 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5514811A
(en)
*
|
1993-02-15 |
1996-05-07 |
Shikoku Chemicals Corporation |
Process for synthesizing 4-halo-5-(hydroxymethyl) imidazole compounds
|
ES2108894T3
(es)
*
|
1993-03-12 |
1998-01-01 |
Lonza Ag |
Procedimiento para la preparacion de 5-cloroimidazoles eventualmente sustituidos en posicion 2.
|
DE4308788A1
(de)
*
|
1993-03-18 |
1994-09-22 |
Bayer Ag |
Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
|
AU679735B2
(en)
*
|
1993-04-07 |
1997-07-10 |
Nissan Chemical Industries Ltd. |
Pyrazole derivative
|
US5451597A
(en)
*
|
1993-05-27 |
1995-09-19 |
G.D. Searle & Co. |
Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists
|
LT3469B
(en)
|
1993-06-02 |
1995-10-25 |
Chem Pharm Forsch Gmbh |
Novel acylales of imidazol-5-carboxylic acid derivatives, process for their preparation and use thereof
|
US5508272A
(en)
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
EP0706508A1
(fr)
*
|
1993-06-30 |
1996-04-17 |
The Wellcome Foundation Limited |
Composes de diaryle contre l'atherosclerose
|
US5610301A
(en)
*
|
1993-07-01 |
1997-03-11 |
American Cyanamid Company |
Process for the regioselective n-alkylation of quinazolinones
|
US5338740A
(en)
*
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
US5342944A
(en)
*
|
1993-07-19 |
1994-08-30 |
American Cyanamid Company |
Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones
|
US5298517A
(en)
*
|
1993-10-07 |
1994-03-29 |
American Cyanamid Company |
Angiotensin II receptor blocking agents
|
US5438136A
(en)
*
|
1993-11-02 |
1995-08-01 |
Merck & Co., Inc. |
Benzo-fused macrocycles promote release of growth hormone
|
US5606054A
(en)
*
|
1993-12-14 |
1997-02-25 |
Merck & Co., Inc. |
Heterocyclic-fused lactams promote release of growth hormone
|
HUT74734A
(en)
*
|
1994-03-16 |
1997-02-28 |
Sankyo Co |
Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
|
US5753672A
(en)
*
|
1994-04-19 |
1998-05-19 |
Tanabe Seiyaku Co., Ltd. |
Imidazopyridine derivatives and process for preparing the same
|
SE9502219D0
(sv)
*
|
1995-06-19 |
1995-06-19 |
Astra Ab |
Novel medical use
|
PL324928A1
(en)
*
|
1995-08-10 |
1998-06-22 |
Sumitomo Chemical Co |
Derivatives of pyrimidin-4-one, their application, intermediate compounds for their production and methods of obtaining such intermediate compounds
|
MY119312A
(en)
*
|
1995-10-06 |
2005-05-31 |
Novartis Ag |
At 1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
|
ATE230263T1
(de)
|
1996-02-29 |
2003-01-15 |
Novartis Erfind Verwalt Gmbh |
At1 rezeptor antagonist zur anregung von apoptosis
|
FR2753195B1
(fr)
|
1996-09-09 |
1998-11-27 |
Sanofi Sa |
Procede pour la preparation d'un cyanobiphenyle
|
JPH10203981A
(ja)
*
|
1997-01-21 |
1998-08-04 |
Kureha Chem Ind Co Ltd |
心疾患改善剤
|
TW418204B
(en)
*
|
1997-03-28 |
2001-01-11 |
Dev Center Biotechnology |
Novel 1,2,4-triazine-5-ketonyl benzene derivatives and the analogs, the preparation, and the pharmaceutical compositions as angiotension II receptor antogonists
|
ES2214013T3
(es)
|
1998-03-04 |
2004-09-01 |
Takeda Chemical Industries Ltd |
Preparacion de liberacion sostenida para un antagonista de aii, su produccion y su uso.
|
DE19820064A1
(de)
*
|
1998-05-06 |
1999-11-11 |
Hoechst Marion Roussel De Gmbh |
Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
CA2334945A1
(fr)
|
1998-06-12 |
1999-12-16 |
Christophe Alain Thurieau |
Derives d'imidazolyles
|
DE19830431A1
(de)
|
1998-07-08 |
2000-01-13 |
Hoechst Marion Roussel De Gmbh |
Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren
|
TR200805275T2
(tr)
|
1998-12-23 |
2008-09-22 |
Novartis Ag |
AT-1 veya AT-2 reseptörlerindeki artışın neden olduğu hastalıkların tedavisi için AT-1 reseptör antagonisti veya AT-2 reseptör modülatörünün kullanımı@
|
US6465502B1
(en)
|
1998-12-23 |
2002-10-15 |
Novartis Ag |
Additional therapeutic use
|
CN101011390A
(zh)
|
1999-01-26 |
2007-08-08 |
诺瓦提斯公司 |
血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
EP1267914B2
(fr)
|
2000-02-04 |
2013-11-06 |
Children's Hospital Research Foundation |
Utilisation de lipase acide lysosomale pour traiter l'atherosclerose et des maladies associees
|
KR20030020960A
(ko)
|
2000-08-01 |
2003-03-10 |
소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. |
이미다졸일 유도체
|
PE20020617A1
(es)
|
2000-08-22 |
2002-08-05 |
Novartis Ag |
Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
|
US8168616B1
(en)
|
2000-11-17 |
2012-05-01 |
Novartis Ag |
Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
|
BR0102252B1
(pt)
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
CA2466659A1
(fr)
|
2001-11-13 |
2003-05-22 |
Takeda Chemical Industries, Ltd. |
Agents anticancer
|
DK3072978T3
(en)
|
2002-05-09 |
2018-09-17 |
Brigham & Womens Hospital Inc |
: 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER
|
PT1535901E
(pt)
|
2002-06-12 |
2008-04-10 |
Sumitomo Chemical Co |
Processo para a produção de 4'-bromometil-2-cianobifenilo
|
AU2003252259A1
(en)
*
|
2002-07-26 |
2004-02-16 |
Nihon Nohyaku Co., Ltd. |
Novel haloalkylsulfonanilide derivatives, herbicides and usage thereof
|
DE10335027A1
(de)
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
DE10306179A1
(de)
|
2003-02-13 |
2004-08-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
GB0316546D0
(en)
|
2003-07-15 |
2003-08-20 |
Novartis Ag |
Process for the manufacture of organic compounds
|
US7491743B2
(en)
|
2003-08-29 |
2009-02-17 |
President And Fellows Of Harvard College |
Inhibitors of cellular necrosis
|
JP4537678B2
(ja)
*
|
2003-09-04 |
2010-09-01 |
住友化学株式会社 |
2’−(1h−テトラゾール−5−イル)ビフェニル−4−カルボアルデヒド結晶およびその製造方法
|
GB0327839D0
(en)
|
2003-12-01 |
2003-12-31 |
Novartis Ag |
Organic compounds
|
ATE546734T1
(de)
|
2003-12-05 |
2012-03-15 |
Cleveland Clinic Foundation |
Risikomarker für eine herzkreislaufkrankheit
|
GB0402262D0
(en)
|
2004-02-02 |
2004-03-10 |
Novartis Ag |
Process for the manufacture of organic compounds
|
TW200605867A
(en)
|
2004-03-17 |
2006-02-16 |
Novartis Ag |
Use of organic compounds
|
ITTO20040264A1
(it)
|
2004-04-28 |
2004-07-28 |
Rotta Res Lab Spa |
Nuovi derivati pirrolici ad attivita' angiotensina-ii antagonista
|
WO2006038223A1
(fr)
*
|
2004-10-06 |
2006-04-13 |
Matrix Laboratories Ltd |
Procede de preparation du 2-n-butyl-4-chloro-1-{[2’-(2-triphenylmethyl-2h-tetrazole-5-yl)-1,1’-biphenyl-4-yl]methyl}-ih-imidazole-5-methanol (intermediaire du losartan)
|
CA2624601C
(fr)
|
2004-10-06 |
2018-07-03 |
The Brigham And Women's Hospital, Inc. |
Pertinence de niveaux obtenus de marqueurs d'inflammation generalisee a la suite d'un traitement
|
ATE551052T1
(de)
|
2004-10-08 |
2012-04-15 |
Novartis Ag |
Verwendung von reninhemmern zur prävention oder behandlung von diastolischer dysfunktion oder diastolischer herzinsuffizienz
|
CN101039917A
(zh)
|
2004-10-15 |
2007-09-19 |
特瓦制药工业有限公司 |
制备替米沙坦的方法
|
CA2585623C
(fr)
|
2004-10-27 |
2012-06-05 |
Daiichi Sankyo Company Limited |
Derives de benzene substitue en position ortho
|
ES2332328T3
(es)
|
2005-02-03 |
2010-02-02 |
Ratiopharm Gmbh |
Procedimiento para la preparacion de losartan.
|
EP1890691A2
(fr)
|
2005-05-31 |
2008-02-27 |
Mylan Laboratories, Inc |
Compositions a base de nebivolol
|
EP1752450A1
(fr)
|
2005-08-01 |
2007-02-14 |
Merck Sante |
Dérives d'imidazole comme inhibiteurs de la fructose-1,6-bisphosphatase et composés pharmaceutiques les contenant
|
WO2007026375A1
(fr)
|
2005-08-31 |
2007-03-08 |
Suven Life Sciences |
Procede de fabrication de losartan
|
US8119358B2
(en)
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
CN101024643A
(zh)
|
2006-02-20 |
2007-08-29 |
上海艾力斯医药科技有限公司 |
咪唑-5-羧酸类衍生物、制备方法及其应用
|
WO2007146229A2
(fr)
|
2006-06-07 |
2007-12-21 |
Tethys Bioscience, Inc. |
Marqueurs associés à des événements artério-vasculaires et procédés d'utilisation de ces marqueurs
|
CN101085772A
(zh)
*
|
2006-06-07 |
2007-12-12 |
上海艾力斯医药科技有限公司 |
一类具有PPARγ激动剂活性的化合物及其应用
|
EP1908469A1
(fr)
|
2006-10-06 |
2008-04-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Antagonistes du récepteur de l'angiotensine II pour traiter des désordres sistémiques des chats
|
AU2006351517B8
(en)
|
2006-12-06 |
2012-01-19 |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
|
CN101214242A
(zh)
|
2007-01-05 |
2008-07-09 |
上海艾力斯医药科技有限公司 |
新的药用组合物
|
ZA200905537B
(en)
|
2007-03-01 |
2010-10-27 |
Probiodrug Ag |
New use of glutaminyl cyclase inhibitors
|
ES2533484T3
(es)
|
2007-04-18 |
2015-04-10 |
Probiodrug Ag |
Derivados de tiourea como inhibidores de la glutaminil ciclasa
|
JP5271350B2
(ja)
|
2007-04-18 |
2013-08-21 |
テシス バイオサイエンス, インコーポレイテッド |
糖尿病に関連するバイオマーカーおよびその使用方法
|
CN101172953B
(zh)
*
|
2007-12-04 |
2011-12-28 |
王俊华 |
沙坦类治疗高血压药物替米沙坦中间体的制备方法
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
US8236843B2
(en)
*
|
2008-09-02 |
2012-08-07 |
Elder Pharmaceuticals Ltd. |
Anti inflammatory compounds
|
EA022007B1
(ru)
|
2009-09-11 |
2015-10-30 |
Пробиодруг Аг |
Гетероциклические производные в качестве ингибиторов глутаминилциклазы
|
TW201201764A
(en)
|
2010-02-01 |
2012-01-16 |
Hospital For Sick Children |
Remote ischemic conditioning for treatment and prevention of restenosis
|
JP6026284B2
(ja)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤
|
KR101790806B1
(ko)
|
2010-03-10 |
2017-11-20 |
프로비오드룩 아게 |
글루타미닐 사이클라제(qc, ec 2.3.2.5)의 헤테로사이클릭 억제제
|
SG10201908570RA
(en)
|
2010-03-31 |
2019-11-28 |
Hospital For Sick Children |
Use of remote ischemic conditioning to improve outcome after myocardial infarction
|
CA2800520A1
(fr)
|
2010-04-08 |
2011-10-13 |
The Hospital For Sick Children |
Utilisation du conditionnement ischemique a distance pour une lesion traumatique
|
EP2560953B1
(fr)
|
2010-04-21 |
2016-01-06 |
Probiodrug AG |
Inhibiteurs de glutaminyl cyclase
|
WO2012123563A1
(fr)
|
2011-03-16 |
2012-09-20 |
Probiodrug Ag |
Dérivés de benzimidazole en tant qu'inhibiteurs de la glutaminyl cyclase
|
WO2012141385A1
(fr)
|
2011-04-12 |
2012-10-18 |
Boryung Pharmaceutical Co., Ltd. |
Composition pharmaceutique antihypertensive
|
EP3173093B1
(fr)
|
2011-07-18 |
2018-12-05 |
Critical Care Diagnostics, Inc. |
Méthodes de traitement de maladies cardiovasculaires et de prédiction de l'efficacité d'une gymnastique rééducative
|
CN103012377A
(zh)
*
|
2011-09-27 |
2013-04-03 |
江苏艾力斯生物医药有限公司 |
一种咪唑-5-羧酸酯的重结晶方法
|
AP2014007766A0
(en)
|
2011-12-15 |
2014-07-31 |
Takeda Pharmaceuticals Usa Inc |
Combination os azilsartan and chlorthlidone for treating hypertension black patients
|
KR20130074808A
(ko)
|
2011-12-16 |
2013-07-05 |
한올바이오파마주식회사 |
스타틴계 지질저하제에 의한 근육계 부작용의 치료 또는 예방을 위한 로사르탄을 포함하는 약제학적 조성물
|
PT2794597T
(pt)
*
|
2011-12-21 |
2018-01-16 |
Ono Pharmaceutical Co |
Derivados de piridinona e pirimidinona como inibidores do fator xia
|
US9265772B2
(en)
|
2012-05-11 |
2016-02-23 |
Reset Therapeutics, Inc. |
Carbazole-containing sulfonamides as cryptochrome modulators
|
EP2879666B1
(fr)
|
2012-08-01 |
2020-04-08 |
Tavakoli, Zahra |
Compositions congelées à écoulement libre comprenant un agent thérapeutique
|
US9725452B2
(en)
|
2013-03-15 |
2017-08-08 |
Presidents And Fellows Of Harvard College |
Substituted indoles and pyrroles as RIP kinase inhibitors
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
WO2018043400A1
(fr)
|
2016-08-30 |
2018-03-08 |
日本曹達株式会社 |
Composé benzamide de sulfonylamino et agent de lutte antiparasitaire
|
KR20200026975A
(ko)
|
2017-07-07 |
2020-03-11 |
베링거잉겔하임베트메디카게엠베하 |
고양이에서 전신 질환의 예방 또는 치료를 위한 안지오텐신 ii 수용체 길항제
|
PL3461819T3
(pl)
|
2017-09-29 |
2020-11-30 |
Probiodrug Ag |
Inhibitory cyklazy glutaminylowej
|